Abstract
Purpose
We aimed to develop a computational simulation model for β-amyloid (Aβ) positron emission tomography (PET) imaging.
Procedures
Model parameters were set to reproduce levels of Aβ within the PDAPP mouse. Pharmacokinetic curves of virtual tracers were computed and a PET detector simulator was configured for a commercially available preclinical PET-imaging system.
Results
We modeled the effects of Aβ therapy and tracer affinity on the ability to differentiate Aβ levels by PET. Varying affinity had a significant effect on the ability to quantitate Aβ. Further, PET tracers for Aβ monomers were more sensitive to the therapeutic reduction in Aβ levels than total brain amyloid. Following therapy, the decrease in total brain Aβ corresponded to the slow rate of change in total amyloid load as expected.
Conclusions
We have developed a first proof-of-concept Aβ-PET simulation model that will be a useful tool in the interpretation of preclinical Aβ imaging data and tracer development.
Similar content being viewed by others
References
T Farkas S Ferris A Wolf et al. (1982) ArticleTitle18F-2-Deoxy-2-Fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia Am J Psychiatry 139 352–353
DF Benson DE Kuhl ME Phelps JL Cummings SY Tsai (1981) ArticleTitlePositron emission computed tomography in the diagnosis of dementia Trans Am Neurol Assoc 106 68–71
V Frouin C Comtat A Reilhac MC Gregoire (2002) ArticleTitleCorrection of partial-volume effect for PET striatal imaging: Fast implementation and study of robustness J Nucl Med 43 1715–1726
V Ibanez P Pietrini GE Alexander et al. (1998) ArticleTitleRegional glucose metabolic abnormalities are not the result of atrophy in Alzheimer’s disease Neurology 50 1585–1593
J Yang SC Huang M Mega et al. (1996) ArticleTitleInvestigation of partial volume correction methods for brain FDG PET studies IEEE Trans Nucl Sci 43 3322–3327 Occurrence Handle10.1109/23.552745
RN Waterhouse (2003) ArticleTitleDetermination of lipophilicity and its use as a predictor of blood–brain barrier penetration of molecular imaging agents Mol Imaging Biol 5 376–389 Occurrence Handle10.1016/j.mibio.2003.09.014
CS Patlak RG Blasberg (1985) ArticleTitleGraphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations J Cereb Blood Flow Metab 5 584–590 Occurrence Handle1:STN:280:BimD3svit10%3D Occurrence Handle4055928
CS Patlak RG Blasberg JD Fenstermacher (1983) ArticleTitleGraphical evaluation of blood-to-brain transfer constants from multiple-time uptake data J Cereb Blood Flow Metab 3 1–7 Occurrence Handle1:STN:280:BiyC3cbjtlI%3D Occurrence Handle6822610
J Logan (2000) ArticleTitleGraphical analysis of PET data applied to reversible and irreversible tracers Nucl Med Biol 27 661–670 Occurrence Handle10.1016/S0969-8051(00)00137-2 Occurrence Handle1:STN:280:DC%2BD3M7htVyltw%3D%3D Occurrence Handle11091109
J Logan JS Fowler ND Volkow et al. (1990) ArticleTitleGraphical analysis of reversible radioligand binding from time–activity measurements applied to [N-11C-methyl]-(−)-cocaine PET studies in human subjects J Cereb Blood Flow Metab 10 740–747
K Shoghi-Jadid GW Small ED Agdeppa et al. (2002) ArticleTitleLocalization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer’s disease Am J Geriatr Psychiatry 10 24–35 Occurrence Handle10.1176/appi.ajgp.10.1.24 Occurrence Handle11790632
DM Skovronsky B Zhang MP Kung HF Kung JQ Trojanowski VM Lee (2000) ArticleTitleIn vivo detection of amyloid plaques in a mouse model of Alzheimer’s disease Proc Natl Acad Sci U S A 97 7609–7614 Occurrence Handle10.1073/pnas.97.13.7609
WE Klunk H Engler A Nordberg et al. (2004) ArticleTitleImaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B Ann Neurol 55 306–319 Occurrence Handle10.1002/ana.20009 Occurrence Handle1:CAS:528:DC%2BD2cXisFKntb8%3D Occurrence Handle14991808
N Okamura T Suemoto H Shimadzu et al. (2004) ArticleTitleStyrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain J Neurosci 24 2535–2541 Occurrence Handle10.1523/JNEUROSCI.4456-03.2004
S Minoshima KA Frey DJ Cross DE Kuhl (2004) ArticleTitleNeurochemical imaging of dementias Semin Nucl Med 34 70–82
FJ Beekman C Kamphuis MA King PP Rijk Particlevan MA Viergever (2001) ArticleTitleImprovement of image resolution and quantitative accuracy in clinical single photon emission computed tomography Comput Med Imaging Graph 25 135–146 Occurrence Handle10.1016/S0895-6111(00)00064-1
H Zaidi (1999) ArticleTitleRelevance of accurate Monte Carlo modeling in nuclear medical imaging Med Phys 26 574–608 Occurrence Handle10.1118/1.598559
H Zaidi AH Scheurer C Morel (1999) ArticleTitleAn object-oriented Monte Carlo simulator for 3D cylindrical positron tomographs Comput Methods Programs Biomed 58 133–145 Occurrence Handle10.1016/S0169-2607(98)00078-9
J Peter DR Gilland RJ Jaszczak RE Coleman R Suganuma K Ogawa (1999) ArticleTitleFour-dimensional superquadric-based cardiac phantom for Monte Carlo simulation of radiological imaging systems IEEE Trans Nucl Sci 46 2211–2227 Occurrence Handle10.1109/23.819306
R Suganuma K Ogawa (2000) ArticleTitleEffective description of a 3D object for photon transportation in Monte Carlo simulation IEEE Trans Nucl Sci 47 1024–1029 Occurrence Handle10.1109/23.856542
LT Baxter F Yuan RK Jain (1992) ArticleTitlePharmacokinetic analysis of the perivascular distribution of bifunctional antibodies and haptens: Comparison with experimental data Cancer Res 52 5838–5844
M Praxmarer C Sung PM Bungay WW Osdol Particlevan (2001) ArticleTitleComputational models of antibody-based tumor imaging and treatment protocols Ann Biomed Eng 29 340–358 Occurrence Handle10.1114/1.1359453
DL Craft LM Wein DJ Selkoe (2002) ArticleTitleA mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer’s brain, CSF and plasma Bull Math Biol 64 1011–1031 Occurrence Handle10.1006/bulm.2002.0304
BJ Bacskai GA Hickey J Skoch et al. (2003) ArticleTitleFour-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice Proc Natl Acad Sci U S A 100 12462–12467 Occurrence Handle10.1073/pnas.2034101100
F Gonzalez-Lima JD Berndt JE Valla D Games EM Reiman (2001) ArticleTitleReduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer’s disease NeuroReport 12 2375–2379 Occurrence Handle10.1097/00001756-200108080-00018
JM Redwine B Kosofsky RE Jacobs et al. (2003) ArticleTitleDentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis Proc Natl Acad Sci U S A 100 1381–1386 Occurrence Handle10.1073/pnas.242746599
J Sijbers (1998) Signal and noise estimation from magnetic resonance images Natuurkunde Universiteit Antwerpen, Antwerpen
RP Brown MD Delp SL Lindstedt LR Rhomberg RP Beliles (1997) ArticleTitlePhysiological parameter values for physiologically based pharmacokinetic models Toxicol Ind Health 13 407–484
M Gibaldi D Perrier (1982) Pharmacokinetics EditionNumber2nd edn. Marcel Dekker New York
A Plenevaux D Weissmann J Aerts et al. (2000) ArticleTitleTissue distribution, autoradiography, and metabolism of 4-(2′-methoxyphenyl)-1-[2′-[N-2′′-pyridinyl)-p-[18F]fluorobenzamido]ethyl]piperazine (p-[18F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An in vivo study in rats J Neurochem 75 803–811 Occurrence Handle10.1046/j.1471-4159.2000.0750803.x
CA Mathis Y Wang DP Holt GF Huang ML Debnath WE Klunk (2003) ArticleTitleSynthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents J Med Chem 46 2740–2754 Occurrence Handle10.1021/jm030026b
TK Lewellen RL Harrison S Vannoy (1998) The SimSET program M Ljungberg SE Strand MA King (Eds) Monte Carlo simulations in nuclear medicine IOP Publishing Bristol 77–92
Shao Y, Manjeshwar RM, Jansen FP, Kumar P (2003) PSM: A PET system modeling capable of generating images with clinically relevant count density. IEEE-MIC M11-191
RM Lewitt G Muehllehner JS Karp (1994) ArticleTitleThree-dimensional reconstruction for PET by multi-slice rebinning and axial image filtering Phys Med Biol 39 321–340 Occurrence Handle10.1088/0031-9155/39/3/002
RB DeMattos KR Bales DJ Cummins SM Paul DM Holtzman (2002) ArticleTitleBrain to plasma amyloid-beta efflux: A measure of brain amyloid burden in a mouse model of Alzheimer’s disease Science 295 2264–2267 Occurrence Handle10.1126/science.1067568 Occurrence Handle1:CAS:528:DC%2BD38XitlGkt7g%3D Occurrence Handle11910111
RB DeMattos KR Bales DJ Cummins JC Dodart SM Paul DM Holtzman (2001) ArticleTitlePeripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer’s disease Proc Natl Acad Sci U S A 98 8850–8855 Occurrence Handle10.1073/pnas.151261398 Occurrence Handle1:CAS:528:DC%2BD3MXls1Wiurk%3D Occurrence Handle11438712
RB DeMattos KR Bales M Parsadanian et al. (2002) ArticleTitlePlaque-associated disruption of CSF and plasma amyloid-β (Aβ) equilibrium in a mouse model of Alzheimer’s disease J Neurochem 81 229–236 Occurrence Handle10.1046/j.1471-4159.2002.00889.x
T Wyss-Coray C Lin F Yan et al. (2001) ArticleTitleTGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice Nat Med 7 612–618 Occurrence Handle10.1038/87945
M Citron (2002) ArticleTitleβ-Secretase as a target for the treatment of Alzheimer’s disease J Neurosci Res 70 373–379 Occurrence Handle10.1002/jnr.10393
DM Walsh I Klyubin JV Fadeeva et al. (2002) ArticleTitleNaturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 535–539 Occurrence Handle10.1038/416535a Occurrence Handle1:CAS:528:DC%2BD38XivVOntL8%3D Occurrence Handle11932745
DM Walsh I Klyubin JV Fadeeva MJ Rowan DJ Selkoe (2002) ArticleTitleAmyloid-β oligomers: Their production, toxicity and therapeutic inhibition Biochem Soc Trans 30 552–557 Occurrence Handle10.1042/BST0300552
MP Kung DM Skovronsky C Hou et al. (2003) ArticleTitleDetection of amyloid plaques by radioligands for Aβ40 and Aβ42: Potential imaging agents in Alzheimer’s patients J Mol Neurosci 20 15–24 Occurrence Handle10.1385/JMN:20:1:15
ED Agdeppa V Kepe J Liu et al. (2001) ArticleTitleBinding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer’s disease J Neurosci 21 IssueID1–5 RC189
HF Kung CW Lee ZP Zhuang MP Kung C Hou K Plossl (2001) ArticleTitleNovel stilbenes as probes for amyloid plaques J Am Chem Soc 123 12740–12741 Occurrence Handle10.1021/ja0167147
YM Kuo MR Emmerling C Vigo-Pelfrey et al. (1996) ArticleTitleWater-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains J Biol Chem 271 4077–4081 Occurrence Handle10.1074/jbc.271.8.4077
JC Dodart KR Bales KS Gannon et al. (2002) ArticleTitleImmunization reverses memory deficits without reducing brain Aβ burden in Alzheimer’s disease model Nat Neurosci 5 452–457
MP Lambert KL Viola BA Chromy et al. (2001) ArticleTitleVaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies J Neurochem 79 595–605 Occurrence Handle10.1046/j.1471-4159.2001.00592.x
C Hock U Konietzko JR Streffer et al. (2003) ArticleTitleAntibodies against β-amyloid slow cognitive decline in Alzheimer’s disease Neuron 38 547–554 Occurrence Handle10.1016/S0896-6273(03)00294-0
JA Nicoll D Wilkinson C Holmes P Steart H Markham RO Weller (2003) ArticleTitleNeuropathology of human Alzheimer disease after immunization with amyloid-β peptide: A case report Nat Med 9 448–452 Occurrence Handle10.1038/nm840 Occurrence Handle1:CAS:528:DC%2BD3sXisVOmu78%3D Occurrence Handle12640446
C Hock U Konietzko A Papassotiropoulos et al. (2002) ArticleTitleGeneration of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease Nat Med 8 1270–1275 Occurrence Handle10.1038/nm783 Occurrence Handle1:CAS:528:DC%2BD38XotlWlsr8%3D Occurrence Handle12379846
H Engler G Blomqvist M Bergstrom et al. (2002) ArticleTitleFirst human study with a benzothiazole amyloid-imaging agent in Alzheimer’s disease and control subjects Neurobiol Aging 23 S429
PM Kemp C Holmes SM Hoffmann et al. (2003) ArticleTitleAlzheimer’s disease: Differences in technetium-99 m HMPAO SPECT scan findings between early onset and late onset dementia J Neurol Neurosurg Psychiatry 74 715–719 Occurrence Handle10.1136/jnnp.74.6.715
H Kitano (2002) ArticleTitleComputational systems biology Nature 420 206–210 Occurrence Handle10.1038/nature01254
BD Sarachan MK Simmons P Subramanian JM Temkin (2003) ArticleTitleCombining medical informatics and bioinformatics toward tools for personalized medicine Methods Inf Med 42 111–115
Y Gong L Chang KL Viola et al. (2003) ArticleTitleAlzheimer’s disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc Natl Acad Sci U S A 100 10417–10422 Occurrence Handle10.1073/pnas.1834302100
R Kayed E Head JL Thompson et al. (2003) ArticleTitleCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 486–489 Occurrence Handle10.1126/science.1079469 Occurrence Handle1:CAS:528:DC%2BD3sXivFyms7k%3D Occurrence Handle12702875
R Deane S Yan ParticleDu RK Submamaryan (2003) ArticleTitleRAGE mediates amyloid-β peptide transport across the blood–brain barrier and accumulation in brain Nat Med 9 907–913 Occurrence Handle10.1038/nm890
R Pluta A Misicka M Barcikowska S Spisacka AW Lipkowski S Januszewski (2000) ArticleTitlePossible reverse transport of beta-amyloid peptide across the blood–brain barrier Acta Neurochir Suppl 76 73–77
BV Zlokovic (1996) ArticleTitleCerebrovascular transport of Alzheimer’s amyloid β and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood–brain barrier Life Sci 59 1483–1497 Occurrence Handle10.1016/0024-3205(96)00310-4 Occurrence Handle1:CAS:528:DyaK28Xmt1Cmt7w%3D Occurrence Handle8890929
JF Poduslo GL Curran B Sanyal DJ Selkoe (1999) ArticleTitleReceptor-mediated transport of human amyloid β-protein 1–40 and 1–42 at the blood–brain barrier Neurobiol Dis 6 190–199 Occurrence Handle10.1006/nbdi.1999.0238
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Simmons, M.K., Manjeshwar, R., Agdeppa, E.D. et al. A Computational Positron Emission Tomography Simulation Model for Imaging β-Amyloid in Mice. Mol Imaging Biol 7, 69–77 (2005). https://doi.org/10.1007/s11307-005-0952-9
Issue Date:
DOI: https://doi.org/10.1007/s11307-005-0952-9